Supreme Court Passes On Schering-Plough Appeal
The U.S. Supreme Court’s rejection came after months of debate between the FTC and the U.S. Solicitor General's office as to whether the justices should hear the case amid the FTC’s wider probe into anti-competitive practices in the prescription drug industry.
Christopher M. Curran, partner at White &...
To view the full article, register now.